Skip to content

Application Process

Apply for Funding

Final call for applications

We are currently accepting applications. This is our final call. No further applications will be accepted to the Psychiatry Consortium after December 2022.

Deadline for submission: 5th December 2022

We are seeking project proposals which focus on the validation of novel molecular drug targets for mental health conditions including: 

  • ADHD
  • Anxiety Disorders
  • Autism Spectrum Disorders
  • Bipolar Disorder
  • Cognitive Disorders
  • Psychiatric Symptoms Associated with Dementia
  • Major Depression
  • OCD
  • Psychotic Disorders (including Schizophrenia)
  • PTSD
  • Stress-related & Panic Disorders

A key priority for us whilst reviewing applications is whether proposals are supported by robust evidence linking the molecular target to human disease and of target modulation having a therapeutic effect.

Application Process

Application Process

  1. Calls for proposals from the research community
  2. Proposal assessment & expression of interest from the consortium members
  3. Project development & approval for funding
  4. Funding awarded & Project delivery through collaboration with CROs

Book a Meeting

We highly recommend that you speak with a member of our team before you apply – we can guide you through the application process and support you as you develop your proposal.

Office 365

If you have a question that you can’t find the answer to